Sensus Healthcare, Inc. (SRTS) stock drops 1.77% in latest session, underperforming market

From Nasdaq: 2024-12-27 18:15:20

In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $7.21, down 1.77% from the previous day, trailing behind the S&P 500, Dow, and Nasdaq. The stock has depreciated by 14.65% in the past month, underperforming the Medical sector and S&P 500.

Analysts are anticipating Sensus Healthcare, Inc. to report an EPS of $0.10, a 61.54% decrease from the previous year. Revenue is expected to be $9.86 million for the quarter, down 21.6% from last year. Full-year estimates project earnings of $0.41 per share and revenue of $38.6 million.

Recent analyst estimate changes for Sensus Healthcare, Inc. suggest optimism about the company’s future performance. The Zacks Rank system, currently at #2 (Buy) for the company, incorporates these changes. With a history of success, Zacks Rank #1 stocks have returned an average annual gain of +25% since 1988.

Sensus Healthcare, Inc. is trading at a Forward P/E ratio of 17.9, below the industry average of 28.48. The Medical – Instruments industry, with a Zacks Industry Rank of 54, ranks in the top 22% of all industries. Utilize Zacks.com for more stock-moving metrics and analysis in upcoming trading sessions.

Zacks is naming the Top 10 Stocks for 2025, with a history of impressive performance. Don’t miss the opportunity to access these top picks for the new year, handpicked by Zacks experts. Follow the link to be among the first to know the top stocks for 2025 and potentially benefit from their success.



Read more at Nasdaq: Sensus Healthcare, Inc. (SRTS) Sees a More Significant Dip Than Broader Market: Some Facts to Know